Citation Tools

Download PDFPDF

Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
Free

Download to a citation manager

Cite this article as:
Spiera R, Jinich S, Jannat-Khah D
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases